IP Library Granted Patent US 8,846,092
Granted Patent B2
US 8,846,092 · App. 13/464,514 · Granted Sep 30, 2014

Gum resin as a carrier for topical application of pharmacologically active agents

Inventors: Alex Battaglia (La Jolla, CA); Eva Beim (La Jolla, CA)
Assignee: Jaleva Pharmaceuticals, LLC
A61Q19/00A61K8/922A61K31/56A61K9/7015A61Q3/00A61Q17/005A61K8/494
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,846,092
App. No.
13/464,514
Granted
Sep 30, 2014
Kind
B2
Abstract

Described are pharmacological compositions comprising a gum resin; a pharmacologically active agent and a topically acceptable volatile solvent for the gum resin and active agent. Also described are methods for the transdermal or transmucosal delivery of a pharmacologically active agent using such compositions.

Claims (20)

1. A method for the transmucosal delivery of a pharmacologically active agent, comprising applying to the mucosa of a subject in need thereof a liquid composition comprising:

(a) a gum resin;

(b) an active agent selected from the group consisting of nicotine, nitroglycerin and scopolamine; and

(c) a topically acceptable volatile solvent for said gum resin and said active agent, at a concentration of 40-90%.

2. The method of claim 1 , comprising applying said composition to a buccal membrane of the subject.

3. The method according to claim 1 , wherein said gum resin is selected from the group consisting of benzoin gum and mastic gum.

4. The method according to claim 1 , wherein said topically acceptable volatile solvent is ethanol and comprises about 60% to 90% of said composition.

5. The method according to claim 1 , wherein said composition further comprises a penetration enhancer.

6. The method according to claim 1 , wherein the active agent is nicotine.

7. The method according to claim 1 , wherein the active agent is nitroglycerin.

8. The method according to claim 1 , wherein the active agent is scopolamine.

9. The method of claim 1 , where the volatile solvent is selected from the group consisting of methanol, ethanol, propanol, isopropanol, and acetone.

10. The method of claim 1 , where the volatile solvent comprises ethanol.

11. The method of claim 1 , where the volatile solvent comprises isopropanol.

12. The method of claim 1 , where the gum resin comprises benzoin, the active agent comprises nicotine, and the volatile solvent comprises isopropanol.

13. The method of claim 1 , wherein the gum resin comprises about 10% to 60% (w/v) of the composition.

14. The method of claim 1 , wherein the gum resin comprises about 20% to 50% (w/v) of the composition.

15. The method of claim 7 , wherein the nitroglycerin comprises 0.5% to 2.0% of the composition.

16. The method of claim 7 , wherein the nitroglycerin comprises 0.5%, 1.0%, or 2.0% of the composition.

17. The method of claim 1 , wherein the volatile solvent comprises about 60% to 90% (v/v) of the composition.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2022
From: BATTAGLIA, ALEX
To: TRIFECTA THERAPEUTICS LLC
Reel/Frame 061860/0065 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 046087 FRAME: 0363. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 21, 2018
From: JALEVA PHARMACEUTICALS, LLC
To: ADVANCED RESIN THERAPEUTICS, INC.
Reel/Frame 046407/0441 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2018
From: JAVELA PHARMACEUTICALS, LLC
To: ADVANCED RESIN THERAPEUTICS, INC.
Reel/Frame 046087/0363 →
CHANGE OF NAME Recorded Mar 31, 2014
From: JALEVA, LLC
To: JALEVA PHARMACEUTICALS, LLC
Reel/Frame 032568/0870 →
Continuity (4)
Continuation 10279704 · Oct 23, 2002
Continuation In Part 10053313 · Jan 18, 2002
Provisional Application 60299377 · Jun 18, 2001
Related Publication 20120220578A1 · Aug 30, 2012